RAIN
Rain Oncology Inc. Common Stock
RAIN
RAIN
Delisted
RAIN was delisted on the 25th of January, 2024.
59 hedge funds and large institutions have $184M invested in Rain Oncology Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 22 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
+13
Holders Change %
+28.26%
% of All Funds
0.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
22
Reduced
9
Closed
2
Calls
$720K
Puts
$1.23M
Net Calls
-$510K
Net Calls Change
-$520K
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$12.7M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$4.07M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.74M |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$2.19M |
| 5 |
GC
GMT Capital
Atlanta,
Georgia
|
+$1.56M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$22.5M |
| 2 |
PA
Perceptive Advisors
New York
|
-$7.3M |
| 3 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.47M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.18M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$192K |
